SCHEMBL3985475

SCHEMBL3985475

COc1cc(N)ccc1NC(=O)S(C)(C)N=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.51
▸ GAA P10253 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ ALDH1A1 P00352 6/20 0.44
▸ HTT P42858 2/20 0.40
▸ RAD52 P43351 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ EPHX1 P07099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986848 0.89 RAD52 (0.50) MAPTGAASMN1; SMN2ALDH1A1RAD52
SCHEMBL3986791 0.80 SIGMAR1 (0.40) MAPTGAARAB9AALDH1A1HTT
SCHEMBL3990362 0.79 PKM (0.66) MAPTGAASMN1; SMN2ALDH1A1HTT
SCHEMBL3985472 0.78 MAPT (0.51) MAPTGAASMN1; SMN2NPC1RAB9A
SCHEMBL16592515 0.77 GAA (0.59) MAPTGAASMN1; SMN2NPC1RAB9A
SCHEMBL6353701 0.77 MAPT (0.59) MAPTGAASMN1; SMN2NPC1RAB9A
SCHEMBL2071884 0.77 GAA (0.59) MAPTGAASMN1; SMN2NPC1RAB9A
SCHEMBL3982267 0.77 LMNA (0.38) MAPTGAASMN1; SMN2NPC1RAB9A
SCHEMBL3979269 0.77 HSD17B10 (0.47) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL10605578 0.75 MAPT (0.57) MAPTGAASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059511-A1 SULPHOXIMIDES AS PROTEIN KINASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2009-05-20 — — EP disclosed
WO-2008025556-A1 SULPHOXIMIDES AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-06 — — WO disclosed
Send feedback